How should a pemphigus patient receiving azathioprine be evaluated and managed for fever?

Fever in Pemphigus Patients on Azathioprine: Urgent Evaluation for Infection

A pemphigus patient on azathioprine (Azoran) presenting with fever requires immediate evaluation for serious bacterial infection, particularly infective endocarditis, with prompt blood cultures, complete blood count, and cardiac assessment—infection is the most life-threatening complication in this immunosuppressed population.

Immediate Diagnostic Workup

Priority Laboratory Tests

• Complete blood count with differential - Check for neutropenia (absolute neutrophil count <1500/mm³) or severe leukopenia, which occurs in >50% of transplant patients on azathioprine and significantly increases infection risk 1
• Blood cultures (at least 2 sets from different sites) before any antibiotics
• Liver function tests - Azathioprine causes hepatotoxicity in <1% of pemphigus patients but can present with fever 1
• Urinalysis and urine culture
• Chest X-ray - Rule out pneumonia, as respiratory infections are common

Critical Cardiac Evaluation

Obtain transthoracic echocardiography if fever persists >48-72 hours or if any cardiac murmur is detected. Infective endocarditis, though rare, has been documented in pemphigus patients on multiagent immunosuppression and can be fatal 2. The diagnosis is particularly challenging because fever of unknown origin is common in immunosuppressed patients, and dermatologists may miss early cardiac signs 2.

Risk Stratification

High-Risk Features Requiring Hospitalization

• Absolute neutrophil count <500/mm³
• Temperature >38.5°C (101.3°F)
• Hemodynamic instability
• Elderly patients (higher adverse event risk) 3
• Patients on multiple immunosuppressants beyond azathioprine 2

Infection Risk Context

The infection rate in pemphigus patients on immunosuppression is substantially elevated. In one Japanese cohort following guideline-based treatment (prednisolone + azathioprine 100mg/day), infections were among the most common adverse events, occurring in 79.8% of patients 3. Severe infections requiring careful monitoring occurred more frequently in elderly patients and those requiring additional therapies 3.

Immediate Management Algorithm

Step 1: Assess Severity (First 1-2 Hours)

• If neutropenic (ANC <1500) or severely ill → Hold azathioprine immediately 1
• If hemodynamically unstable → Admit to hospital, start empiric broad-spectrum antibiotics after cultures
• If stable with mild leukopenia → Can continue azathioprine with close monitoring

Step 2: Source Identification (First 24 Hours)

Look specifically for:

• Skin/mucosal lesions - Secondary bacterial infection of pemphigus erosions
• Cardiac murmurs - New or changing murmurs suggest endocarditis 2
• Respiratory symptoms - Pneumonia (including opportunistic organisms)
• Urinary symptoms - UTI/pyelonephritis
• Gastrointestinal symptoms - If accompanied by abdominal pain, consider hypersensitivity pancreatitis (rare but occurs with azathioprine) 1

Step 3: Azathioprine Management Decision

Temporarily discontinue azathioprine if:

• WBC <2500 cells/mm³ 1
• Absolute neutrophil count <1000/mm³
• Confirmed serious bacterial infection
• Fever with no identified source after 48 hours

Continue azathioprine with increased monitoring if:

• Mild leukopenia (WBC 2500-4000) with identified, treatable infection source
• Fever resolves within 24-48 hours with treatment

Drug Interaction Considerations

Critical Drug Interactions Increasing Infection Risk

• Co-trimoxazole (often used for PCP prophylaxis) - Causes exaggerated leukopenia when combined with azathioprine 1
• ACE inhibitors - Can induce severe leukopenia and anemia 1
• Allopurinol/febuxostat - If patient is on these for gout, azathioprine dose should already be reduced to 1/3-1/4 usual dose; if not, this may explain toxicity 1

Monitoring Protocol During Fever Episode

• Daily CBC until fever resolves and infection controlled
• Blood cultures every 48-72 hours if fever persists
• Clinical reassessment every 24 hours for new signs of infection or endocarditis

Common Pitfalls to Avoid

1. Assuming fever is from pemphigus disease activity - In immunosuppressed patients, always assume infection until proven otherwise
2. Missing infective endocarditis - Maintain high index of suspicion; this diagnosis is easily overlooked and can be fatal 2
3. Continuing azathioprine during neutropenia - Dose-dependent myelosuppression can be severe and life-threatening; temporary withdrawal allows reversal 1
4. Inadequate cardiac evaluation - Don't rely on symptoms alone; endocarditis can present subtly in immunosuppressed patients 2

When to Resume Azathioprine

• Infection clinically resolved
• WBC >3000 cells/mm³ and stable
• ANC >1500/mm³
• Consider restarting at reduced dose (50-75% of previous dose) with weekly CBC monitoring for first month 1

The British Association of Dermatologists guidelines support azathioprine as a well-established adjuvant for pemphigus, but emphasize that treatment efficacy should be balanced against toxicity risk 4, 5. In the context of fever, infection prevention and early detection take absolute priority over maintaining immunosuppression.